Fennec Pharmaceuticals Inc. (NASDAQ: FENC), a biotechnology company focused on the development of PEDMARKTM (a unique formulation of sodium thiosulfate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE